Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
BUSINESS Kissei Files Rigel’s AML Drug Olutasidenib in Japan
May 28, 2026
-
BUSINESS Japan OTC Market Falls 2.4% in April amid Weaker Inbound Demand: Intage
May 28, 2026
-
BUSINESS Astellas Sees Sales Decline through FY2029 on Xtandi LOE, Maps 200 Billion Yen Cuts in 5 Years
May 27, 2026
-
REGULATORY MHLW Panel Deems 4 More “Drug Loss” Products as High-Need
May 27, 2026
-
REGULATORY LDP Panel OKs Immunization Act Bill Aimed at Beyfortus NIP Use
May 27, 2026
-
REGULATORY Japan Selects JN.1 Substrains for COVID Vaccines in 2026-2027 Season
May 27, 2026
-
BUSINESS ASKA Set to Seek Shareholder OK for Faster Poison Pill Activation
May 27, 2026
-
REGULATORY Ex-Minister Kato Preparing Parliamentary Group on Diabetes Issues
May 27, 2026
-
REGULATORY LDP Lawmakers’ League Urges Economic Efficiency in Drug Use
May 27, 2026
-
BUSINESS Eylea Biosimilar Shipment Restrictions to Be Lifted on June 5
May 27, 2026
-
BUSINESS Bayer’s Low-Dose MRI Contrast Agent Ambelvist Debuts in Japan
May 27, 2026
-
REGULATORY US Calls Out Japan’s Market Expansion Re-Pricing Rules as “Unfair”: IP Report
May 26, 2026
-
REGULATORY CEA Review Group Holds First Meeting, Technical Debate Yet to Begin
May 26, 2026
-
REGULATORY AstraZeneca’s Oral SERD, MSD RSV Antibody Clear Japan Panel Review
May 26, 2026
-
BUSINESS Eisai Eyes 1 Trillion yen in FY2028 Sales under 3-Year Plan
May 26, 2026
-
BUSINESS Nippon Kayaku to Take Over AstraZeneca’s Zoladex in Japan
May 26, 2026
-
BUSINESS Jardiance Triumphs in Six Promotion Channels in April: Intage
May 26, 2026
-
BUSINESS NTT Data, Kindai Hospital Validate RWD-Based Patient Screening Technology
May 26, 2026
-
BUSINESS Enhertu Earns EMA Panel OK for HER2 Positive Solid Tumors
May 25, 2026
-
BUSINESS Datroway Snares US Approval in 1st-Line TNBC: Daiichi Sankyo
May 25, 2026
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…